Redsense Medical AB (RDSNF)
0.51
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Redsense Medical Profit Margin (Quarterly) : 17.48% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 17.48% |
| December 31, 2025 | -30.56% |
| September 30, 2025 | -4.97% |
| June 30, 2025 | -29.16% |
| March 31, 2025 | -66.00% |
| December 31, 2024 | 44.37% |
| September 30, 2024 | -65.02% |
| June 30, 2024 | 7.15% |
| March 31, 2024 | -154.3% |
| December 31, 2023 | -11.84% |
| September 30, 2023 | -19.06% |
| June 30, 2023 | -61.40% |
| March 31, 2023 | 6.06% |
| December 31, 2022 | -28.62% |
| Date | Value |
|---|---|
| September 30, 2022 | -231.8% |
| June 30, 2022 | -110.9% |
| March 31, 2022 | -49.57% |
| December 31, 2021 | -30.84% |
| September 30, 2021 | -71.41% |
| June 30, 2021 | -217.8% |
| March 31, 2021 | -74.32% |
| December 31, 2020 | -238.5% |
| September 30, 2020 | -152.5% |
| June 30, 2020 | 1.77% |
| March 31, 2020 | 4.82% |
| December 31, 2019 | -28.36% |
| September 30, 2019 | -12.70% |
| June 30, 2019 | -50.33% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Elekta AB | -18.12% |
| Surgical Science Sweden AB | 7.91% |
| Senzime AB | -96.90% |
| Acarix AB | -362.2% |
| Accuray, Inc. | -11.26% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.98% |
| Return on Assets | -7.19% |
| Return on Invested Capital | -7.98% |
| Gross Profit Margin (Quarterly) | 10.28% |
| Operating Margin (Quarterly) | 10.28% |
| Return on Net Operating Assets | -10.38% |